Delivery Order SPE2DB22D1106-SPE2DB25FFGA9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,071.48 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99...
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $5,245.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count package) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $16,100.02 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages). The contract is classified as firm fixed price with no set-aside designation, indicating competitive award. Performance is scheduled to conclude by August 20, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of NURTEC ODT 75 MG tablets (eight count) with a ceiling value of $10,819.64. This firm fixed price delivery order, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,637.29 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packaging) under a firm fixed-price contract with a ceiling value of $2,564.82. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $33,700.47 for NURTEC ODT 75 mg tablets (8-count units) on August 25, 2025, with completion anticipated by August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,431.99 on August 28, 2025, for NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGA9Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,177.74 on August 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 2, 2025, with performance executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, specialty treatments, and medical devices across multiple therapeutic domains. This delivery order for NURTEC ODT, a migraine treatment medication, is consistent with the contractor's established role in supplying neurological and specialty pharmaceutical products to support Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.2k | 8/29/25 |